Predictive Factors of Pseudoprogression in Vestibular Schwannoma Treated with Fractionated Stereotactic Radiotherapy

被引:0
作者
Lo, A. W. S. [1 ]
Nyaw, S. F. [2 ]
Mui, W. H. [2 ]
Huang, J. J. [2 ]
Kam, K. M. [3 ]
Wong, C. S. [2 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China
来源
HONG KONG JOURNAL OF RADIOLOGY | 2019年 / 22卷 / 03期
关键词
Neuroma; acoustic; Radiotherapy; Risk factors; ACOUSTIC NEUROMAS; RADIOSURGERY; RADIATION; MANAGEMENT; EXPANSION; SURGERY;
D O I
10.12809/hkjr1916934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Fractionated stereotactic radiotherapy (FSRT) is a well-established treatment for vestibular schwannoma (VS). Tumour pseudoprogression may lead to worsening symptoms leading to the necessity of urgent salvage surgery. This study aimed to assess the predictive factors of pseudoprogression and treatment related toxicities in VS treated with FSRT. Methods: This retrospective cohort study included all patients with VS treated with FSRT between 1999 and 2015. Risk factors assessed included sex, age, previous surgical resection, tumour diameter, gross tumour volume, planning target volume, overall treatment time, equivalent dose in 2-Gy fractions, and the presence of brainstem or cerebellar compression prior to radiotherapy. Fisher's exact test and two-sample t test were used for statistical analysis. Results: Eighteen patients were included. The median follow-up time was 80.3 months. The overall disease control rate after FSRT was 94.4%. Of the 18 patients, one (5.6%) developed local tumour progression, seven (38.9%) underwent tumour pseudoprogression; and 10 (55.6%) had stable disease. Median time to tumour pseudoprogression was 8.63 months (range, 4.5-13.1 months). Tumours with pseudoprogression and those with at least stable disease had a mean diameter of 2.7 cm and 2.1 cm, respectively (p = 0.18). The mean treatment planning target volume in the pseudoprogression group was larger than that in the non-progression group with volume measured (22.2 cc vs. 10.0 cc; p = 0.04). Patients with brainstem or cerebellar compression observed on magnetic resonance imaging before radiotherapy were associated with a higher risk of pseudoprogression (p = 0.0498). The overall salvage surgery rate was 17.7%. Conclusion: Upfront surgery may be more desirable than FSRT for those surgically fit patients with considerable treatment volume and evidence of mass effect. Large prospective studies are needed to confirm our findings and to identify further predictive factors for pseudoprogression.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [41] Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
    Eichkorn, Tanja
    Regnery, Sebastian
    Held, Thomas
    Kronsteiner, Dorothea
    Hoerner-Rieber, Juliane
    El Shafie, Rami A.
    Herfarth, Klaus
    Debus, Juergen
    Koenig, Laila
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy
    Patel, Mira A.
    Marciscano, Ariel E.
    Hu, Chen
    Jusue-Torres, Ignacio
    Garg, Rupen
    Rashid, Arif
    Francis, Howard W.
    Lim, Michael
    Redmond, Kristin J.
    Rigamonti, Daniele
    Kleinberg, Lawrence R.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [43] Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma
    Tolisano, Anthony M.
    Hunter, Jacob B.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2019, 80 (02) : 156 - 164
  • [44] Fractionated radiation therapy for vestibular schwannoma
    Jian, Brian J.
    Kaur, Gurvinder
    Sayegh, Eli T.
    Bloch, Orin
    Parsa, Andrew T.
    Barani, Igor J.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (07) : 1083 - 1088
  • [45] Matched Comparison of Hearing Outcomes in Patients With Vestibular Schwannoma Treated With Stereotactic Radiosurgery or Observation
    Schnurman, Zane
    Gurewitz, Jason
    Smouha, Eric
    McMenomey, Sean O.
    Roland, J. Thomas, Jr.
    Golfinos, John G.
    Kondziolka, Douglas
    NEUROSURGERY, 2022, 91 (04) : 641 - 647
  • [46] Dosimetric predictive factors for facial nerve paralysis after cyberknife® stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients
    Gehin, William
    Lassalle, Benoite
    Salleron, Julia
    Anxionnat, Rene
    Peiffert, Didier
    Marchesi, Vincent
    Bernier-Chastagner, Valerie
    RADIOTHERAPY AND ONCOLOGY, 2023, 181
  • [47] Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution
    Puataweepong, Putipun
    Dhanachai, Mantana
    Dangprasert, Somjai
    Narkwong, Ladawan
    Sitathanee, Chomporn
    Sawangsilpa, Thiti
    Janwityanujit, Taweesak
    Yongvithisatid, Pornpan
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (02) : 351 - 358
  • [48] Treatment of a Large Acoustic Tumor with Fractionated Stereotactic Radiotherapy
    McClelland, Shearwood, III
    Gerbi, Bruce J.
    Cho, Kwan H.
    Hall, Walter A.
    RADIOSURGERY, VOL 7, 2010, 7 : 169 - 174
  • [49] Fractionated stereotactic radiotherapy for acoustic neuromas
    Williams, JA
    ACTA NEUROCHIRURGICA, 2002, 144 (12) : 1249 - 1254
  • [50] Fractionated stereotactic radiotherapy for acoustic neuromas
    Williams, JA
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2002, 78 (01) : 17 - 28